These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23566246)

  • 21. Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia.
    Ge CJ; Lu SZ; Chen YD; Wu XF; Hu SJ; Ji Y
    Heart Vessels; 2008 Mar; 23(2):91-5. PubMed ID: 18389332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic relevance of left ventricular diastolic function parameters in dilated cardiomyopathy].
    Schannwell CM; Schoebel FC; Marx R; Plehn G; Leschke M; Strauer BE
    Z Kardiol; 2001 Apr; 90(4):269-79. PubMed ID: 11381575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of atorvastatin (10 mg) on systemic inflammation in heart failure.
    Mozaffarian D; Minami E; Letterer RA; Lawler RL; McDonald GB; Levy WC
    Am J Cardiol; 2005 Dec; 96(12):1699-704. PubMed ID: 16360360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia.
    Milionis HJ; Papakostas J; Kakafika A; Chasiotis G; Seferiadis K; Elisaf MS
    J Clin Pharmacol; 2003 Aug; 43(8):825-30. PubMed ID: 12953339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction.
    Tang XL; Sanganalmath SK; Sato H; Bi Q; Hunt G; Vincent RJ; Peng Y; Shirk G; Dawn B; Bolli R
    PLoS One; 2011; 6(9):e25320. PubMed ID: 21980426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
    Vrtovec B; Poglajen G; Lezaic L; Sever M; Domanovic D; Cernelc P; Socan A; Schrepfer S; Torre-Amione G; Haddad F; Wu JC
    Circ Res; 2013 Jan; 112(1):165-73. PubMed ID: 23065358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure.
    Vrtovec B; Okrajsek R; Golicnik A; Ferjan M; Starc V; Schlegel TT; Radovancevic B
    J Card Fail; 2008 Mar; 14(2):140-4. PubMed ID: 18325461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating proinflammatory cytokines and N-terminal pro-brain natriuretic peptide significantly decrease with recovery of left ventricular function in patients with dilated cardiomyopathy.
    Ahmad S; Otaal PS; Rai TS; Bahl A; Saikia UN; Manoj RK; Thungapathra M; Talwar KK; Khullar M
    Mol Cell Biochem; 2009 Apr; 324(1-2):139-45. PubMed ID: 19107325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statins do not significantly affect muscle sympathetic nerve activity in humans with nonischemic heart failure: a double-blind placebo-controlled trial.
    Horwich TB; Middlekauff HR; Maclellan WR; Fonarow GC
    J Card Fail; 2011 Nov; 17(11):879-86. PubMed ID: 22041323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia.
    Milionis HJ; Kakafika AI; Tsouli SG; Athyros VG; Bairaktari ET; Seferiadis KI; Elisaf MS
    Am Heart J; 2004 Oct; 148(4):635-40. PubMed ID: 15459594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarker assessment of the immunomodulator effect of atorvastatin in stable renal transplant recipients and hypercholesterolemic patients.
    Guillén D; Cofán F; Ros E; Millán O; Cofán M; Brunet M
    Mol Diagn Ther; 2010 Dec; 14(6):357-66. PubMed ID: 21047146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy.
    Van Linthout S; Riad A; Dhayat N; Spillmann F; Du J; Dhayat S; Westermann D; Hilfiker-Kleiner D; Noutsias M; Laufs U; Schultheiss HP; Tschöpe C
    Diabetologia; 2007 Sep; 50(9):1977-1986. PubMed ID: 17589825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypotensive effect of atorvastatin is not related to changes in inflammation and oxidative stress.
    Kuklińska AM; Mroczko B; Musiał WJ; Sawicki R; Kozieradzka A; Usowicz-Szaryńska M; Kamiński K; Knapp M; Szmitkowski M
    Pharmacol Rep; 2010; 62(5):883-90. PubMed ID: 21098871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heart failure biomarkers in patients with dilated cardiomyopathy.
    Bielecka-Dabrowa A; von Haehling S; Aronow WS; Ahmed MI; Rysz J; Banach M
    Int J Cardiol; 2013 Oct; 168(3):2404-10. PubMed ID: 23416015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy.
    Kurum T; Tatli E; Yuksel M
    Tex Heart Inst J; 2007; 34(1):52-9. PubMed ID: 17420794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
    Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
    Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress.
    Kishimoto C; Shioji K; Kinoshita M; Iwase T; Tamaki S; Fujii M; Murashige A; Maruhashi H; Takeda S; Nonogi H; Hashimoto T
    Int J Cardiol; 2003 Oct; 91(2-3):173-8. PubMed ID: 14559127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.
    Goicoechea M; de Vinuesa SG; Lahera V; Cachofeiro V; Gómez-Campderá F; Vega A; Abad S; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S231-5. PubMed ID: 17130267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between inflammation and oxidative stress in normocholesterolemic coronary artery disease patients 'on' and 'off' atorvastatin for short time intervals.
    Thomas MK; Narang D; Lakshmy R; Gupta R; Naik N; Maulik SK
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):37-44. PubMed ID: 16534549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.